ID   IARC-305
AC   CVCL_VQ46
SY   IARC 305; IARC/305; IARC305
DR   DSMZ; ACC-928
DR   Wikidata; Q94312146
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Doubling time: ~2-4 days (DSMZ=ACC-928).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-928
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D21S11: 29,32.2
ST   D2S1338: 16,17
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23,26
ST   Penta D: 13,14
ST   Penta E: 7,17
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C163 ! BL-65
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 8
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//